Management to Showcase the Nature-Cide Product Portfolio to Industry Decision Makers at Leading Industry Conference

LOS ANGELES, CA / ACCESSWIRE / October 10, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that the Company will attend PestWorld Boston 2022 - a leading event in the pest control industry - taking place October 11-14, 2022 in Boston, Massachusetts.

Every year, the National Pest Management Association (NPMA) gathers thousands of pest management professionals and industry suppliers from across the globe to offer opportunities for networking and collaboration at PestWorld. The NPMA, a non-profit organization with nearly 5,000 members from around the world, was established in 1933 to support the pest management industry's commitment to the protection of public health, food and property.

PestWorld Boston 2022
Date: October 11-14, 2022
Location: John B. Hynes Veterans Memorial Center | Boston, MA
Booth: 1005

"I look forward to showcasing our Nature-Cide family of products to countless potential customers at PestWorld Boston 2022, a premier event within the broader pest control industry," said Greg Pettis VP of Business Development at Med-X. "Our ability to offer truly safe alternatives to outdated poisonous chemicals often used in pest control has proven popular with consumers and pest control professionals alike, and we are eager to share our capabilities with industry decision makers at PestWorld."

About Med-X, Inc.

Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .

Disclaimer and Forward-Looking Statements

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). This announcement is being issued in accordance with Rule 135 of the Securities Act. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events.

Investor Relations Contact
Lucas Zimmerman
Director
MZ Group - MZ North America
262-357-2918
MXRX@mzgroup.us

SOURCE: Med-X, Inc.